Bristol-Myers Squibb (BMY)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 6 |
Ownership rank: | 67 |
% of all portfolios: | 0.151% |
Hold Price * : | $52.60 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
3 |
$672,994 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Kahn Brothers Group |
6.74 |
Reduce 2.09% |
833,916 |
42,788,000 |
≡ |
Richard Pzena - Hancock Classic Value |
2.44 |
|
758,664 |
41,142,000 |
≡ |
Bill Miller - Miller Value Partners |
2.24 |
Buy |
60,000 |
3,254,000 |
≡ |
Dodge & Cox |
0.57 |
|
11,355,339 |
615,800,000 |
≡ |
David Katz - Matrix Asset Advisors |
0.04 |
Add 2.00% |
5,549 |
301,000 |
≡ |
Jensen Investment Management |
0.01 |
|
26,375 |
1,430,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
07 Dec 2023 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
05 Dec 2023 |
2,000 |
49.78 |
99,560 |
30 Nov 2023 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
28 Nov 2023 |
3,071 |
48.86 |
150,049 |
21 Nov 2023 |
SAMUELS THEODORE R. II |
Director |
20 Nov 2023 |
8,500 |
49.81 |
423,385 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock